Recent Developments

Lee & Ko Attorneys Keum Nang Park of the Healthcare Group have been named to Benchmark Litigation Asia-Pacific’s ‘Top 100 Women in Litigation 2026’ in recognition of their outstanding achievements in healthcare-related patent and regulatory disputes, as well as major competition law matters.

Ms. Park serves as Co-Head of Lee & Ko’s Healthcare Group, advising clients on intellectual property matters—including pharmaceutical and biotechnology patents—as well as a broad range of regulatory matters involving the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, and the Ministry of Environment. She brings deep and wide-ranging expertise across the healthcare industry, including pharmaceuticals, medical devices, cosmetics, food, dietary supplements and household chemical products. Ms. Park was named to this year’s list in recognition of her success in defending market exclusivity on behalf of the patent holder of a world-renowned cardiovascular blockbuster drug, prevailing in more than 100 patent suits brought by numerous generic manufacturers. Her selection also reflects her achievements in protecting patent rights in litigation involving a widely used blockbuster biologic for chronic inflammatory disease and a prominent blockbuster biologic for ophthalmic disease.

Benchmark Litigation, published by Delinian, formerly Euromoney, is a globally renowned publication focusing on dispute resolution and litigation. Its annual ‘Top 100 Women in Litigation’ list recognizes 100 leading female litigators in the Asia-Pacific region based on months of in-depth research and analysis.

Lee & Ko was honored with six awards in four categories at the recent Asialaw Awards 2022 held on September 28, 2022, winning the most prizes among Korean law firms.

The six trophies awarded to Lee & Ko include South Korea Firm of the Year, Dispute Resolution Firm of the Year, and Regulatory Firm of the Year, as well as three Impact Deal & Case of the Year Awards in the fields of health care, serious disaster, and labor.

Following its success as being named the best law firm in all fields in Asialaw’s annual evaluation in September, Lee & Ko was once again named as best among its peers for its outstanding expertise at this year’s celebration, winning the most awards among domestic law firms. 

Asialaw Award is given by Asialaw, which is an affiliate of the global financial journal Euromoney.  Each year, the awards celebrate leading law firms across 11 practice areas, 7 industries and 23 jurisdictions in the Asia-Pacific region.

Keum Nang Park, an attorney at Lee & Ko was selected as 2022 ‘Top 100 Women in Litigation’ for the Asia-Pacific region as published by Benchmark Litigation.

Ms. Park is the Co-head of the Healthcare/Life Science Group at Lee & Ko and possesses ample experience in matters involving intellectual property rights and healthcare, including pharmaceutical bio patents. Her in-depth knowledge in various areas including intellectual property laws, Ministry of Health and Welfare, Ministry of Food and Drug Safety, Ministry of Environment makes her highly capable of handling a wide range of cases in the areas of pharmaceuticals, medical devices, cosmetics, food, health functional foods, and consumer products. 

Benchmark Litigation, published by Euromoney, is a world-renowned publication which highlights the fields of dispute resolution and litigation and publishes rankings of ‘Asia-Pacific’s Top 100 Women in Litigation’ by selecting 100 female lawyers in the Asia-Pacific region who have received excellent ratings based on months of in-depth analysis.